Massive liver cancer registry reveals how targeted radiation performs in everyday practice
NCT ID NCT02305459
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This study observed over 1,000 adults with liver cancer who received SIR-Spheres, tiny radioactive beads delivered directly to liver tumors. Researchers tracked how doctors used the treatment in real-world settings, along with side effects, survival, and quality of life. The goal was to gather practical information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardiovascular and Interventional Radiological Society of Europe
Vienna, 1010, Austria
Conditions
Explore the condition pages connected to this study.